Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

TransAlta Reports Strong Q4 Earnings and Launches Share Buyback Program

Elaine Mendonca by Elaine Mendonca
February 23, 2024
in Breaking News
0
Electric Utilities Stock Exchange
0
SHARES
12
VIEWS
Share on FacebookShare on Twitter

TransAlta’s stock prices have surged following the release of their Q4 earnings report and the unveiling of a new common share buyback program worth up to C$150 million. The company’s financial performance for the fourth quarter and full year ending on December 31, 2022, surpassed expectations, with adjusted EBITDA and Free Cash Flow exceeding projections.

In the final quarter of 2023, TransAlta reported a total loss of $84 million, while generating $624 million in revenue. Furthermore, Free Cash Flow for the three months ending on December 31, 2023, amounted to $121 million, a decrease from $315 million in the same period in 2022.

Overall, TransAlta’s strong financial results demonstrate their continued commitment to delivering value to shareholders and driving sustainable growth.

February 23, 2024: TAC Stock Shows Promising Signs of Turnaround with 5.58% Price Increase

On February 23, 2024, TAC stock showed some promising signs of a potential turnaround as it saw a 5.58% increase in its price. By the time the market closed, the price had increased by $0.39, marking a significant gain for investors who had been holding onto the stock. Investors will be watching closely to see if this momentum continues in the days and weeks ahead. Overall, TAC’s performance on February 23, 2024, was a bright spot in what had been a challenging period for the stock. Investors may have reason to be optimistic about the future prospects of TAC.

February 23, 2024: TAC Stock Impresses with Strong Financial Performance

On February 23, 2024, TAC stock showed impressive performances based on the financial data provided by CNN Money. The company’s total revenue stood at $2.19 billion for the past year, which remained flat compared to the previous year. However, there was a significant increase of 62.94% in total revenue since the last quarter, reaching $758.24 million. Furthermore, TAC reported a net income of $38.41 million for the past year, showing an impressive increase of 108.97% compared to the previous year. The net income for the last quarter was even more remarkable, standing at $287.79 million, which represents a staggering growth of 422.32% since the previous quarter. In terms of earnings per share (EPS), TAC reported $0.01 for the past year, marking a 100.67% increase compared to the previous year. The EPS for the last quarter was $1.05, showing an impressive growth of 502.97% since the previous quarter. Overall, TAC stock showed strong performances on February 23, 2024, with impressive growth in total revenue, net income, and earnings per share. Investors and analysts may view these positive financial indicators as a sign of the company’s strong financial health and potential for future growth.

Tags: TAC
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Retail Stock Bull Market

Investors Show Confidence in Abercrombie Fitch NYSE ANF Through Options Trading

Healthcare Services Stock Exchange

Strong FourthQuarter Performance Leads to Analyst Price Target Adjustments for Evolent Health Inc

Telecommunications Industry stock Trading

Verizons Strategic Growth and Success in 2024

Recommended

Anticipating Navigator Holdings Quarterly Earnings Report Analysts Predict 030 EPS

2 years ago
Sandy Spring Stock

Sandy Spring Bancorp’s Final Chapter: A New Era Under Atlantic Union

3 months ago
Certara Stock

Certara Stock: Regulatory Milestone and Strong Fundamentals Fuel Recovery Hopes

6 months ago
Meta Stock

Meta Faces Mounting Pressure from Regulators and Strategic Shifts

2 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Vir Biotechnology’s 2026 Pipeline: A Year of Pivotal Clinical Data

Tellurian Acquisition Finalized as Woodside Takes Control

Coherus BioSciences Forges Key Oncology Alliance with Janssen

TCG BDC Investors Await Key Financial Milestones

Navigating Change: Schnitzer Steel’s Digital and Structural Evolution

Akso Health Group Pivots to Oncology with Global Patient Initiative

Trending

Deluxe Stock
Analysis

Deluxe Stock Gains Momentum on Successful Fintech Transition

by Kennethcix
February 6, 2026
0

Deluxe Corporation is successfully shedding its legacy identity as a check-printing specialist. The company's strategic pivot toward...

Hydrofarm Holdings Inc Stock

Hydrofarm Holdings: Q4 2025 Earnings Report Date Approaches

February 6, 2026
Northeast Bancorp Stock

Northeast Bancorp Reports Robust Loan Growth Amid Strong Quarterly Performance

February 6, 2026
Vir Biotechnology Stock

Vir Biotechnology’s 2026 Pipeline: A Year of Pivotal Clinical Data

February 6, 2026
Tellurian Stock

Tellurian Acquisition Finalized as Woodside Takes Control

February 6, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Deluxe Stock Gains Momentum on Successful Fintech Transition
  • Hydrofarm Holdings: Q4 2025 Earnings Report Date Approaches
  • Northeast Bancorp Reports Robust Loan Growth Amid Strong Quarterly Performance

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com